CFFA is incorporating the newest advancements to provide our patients with the latest technology to prevent further complications and heal them as quickly as possible.
Recently Dr. Wellens took a training course at the Regenerative Medicine Training Institute in South Florida with leaders in this field, Dr. Joseph Purita and Dr. Paul Tortland. The course was on cutting-edge updates in science regenerative therapy as well as treatment protocols and improving patient outcomes.
What Dr. Wellens was able to discover by attending this course is now we are able to aspirate bone marrow, which is rich in the patient’s own stem cells, from the heel bone called calcaneus. We then will use the isolated stem cells to inject tendons and joints with minimally invasive techniques in a clinical setting. This means that patients can undergo a minimally invasive procedure with better surgical outcomes and reduced recuperation time unless complications occur which can happen during any procedure.
Dr. Wellens earned a diploma for completing the educational course in Techniques and Clinical Applications for Bone Marrow and Adipose Aspiration Procedures.
She will now be bringing stem cell healing, PRP therapy, bone marrow, and growth factors to the healing process of her patients.
Central Florida Foot & Ankle is proud to announce that we have introduced regenerative medicine into our practice. We will utilize the wound matrix, regenerative matrix, and particular matrix in order to provide top notch advanced medical care to our patients. We have partnered with Amniox Medical Technology, who is a leader in restorative tissue therapy. Amniox has over 25 years of National Institute of Health Sponsored Research, over 130,000 human implants, and 300 peer reviewed scientific publications.
We have introduced three different products that we will commonly utilize in office as well as surgically.
Clarix Flo is the particulate form of Clarix and cord regenerative medicine that employs the benefits of umbilical cord providing higher volumes of critical matrix protein innate to the tissue.
The procedure involves an injection that can be performed in the office in order to facilitate regeneration of tendon healing as well as is also indicated for osteoarthritis and other degenerative processes.
We will also utilize Clarix regenerative matrix for utilization in surgical coverings, wraps, and barriers. The matrix is indicated for use as a surgical membrane or graft and stimulates growth of new tendons. The bioactive matrix contains unique matrix proteins that regulate inflammation and prevents scar formation that may lead to limited functional recovery, poor cosmesis and subsequent surgery or excessive medical management. Clarix matrix is made from cryopreserved human amniotic membrane and umbilical cord, utilizing the patented cryo tech process. Dr. Wellens and Dr. Jaramillo are planning to use this in future repair of Achilles tendons, peroneal tendons, and posterior tibial tendon tears.
Neox Wound Matrix is indicated as a wound covering for dermal ulcers and defect and Central Florida Foot & Ankle is planning to widely introduce it on the market in September of 2015 for covering chronic wounds. Neox Wound Matrix is made from cryopreserved human amniotic membrane and umbilical cord, using the patented cryo tech process. This process method is scientifically proven to maintain the innate physical and biological properties of the tissues. In clinical trials, it had been shown to significantly increase the rate of wound healing.
Please call Central Florida Foot and Ankle Center, LLC and schedule a consultation for further information on those three new products.
Case Studies: (May Contain Graphic Images)
- Use of Cryopreserved, Particulate Human Amniotic Membrane and Umbilical Cord (AM/UC) Tissue: A Case Series Study for Application in the Healing of Chronic Wounds
- An Open-label, Single-center, Retrospective Study of Cryopreserved Amniotic Membrane and Umbilical Cord Tissue as an Adjunct for Foot and Ankle Surgery
- Cryopreserved Human Amniotic Membrane Injection for Plantar Fasciitis: A Randomized, Controlled, Double-Blind Pilot Study